STOCK TITAN

SLB Limited Financials

SLB
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows SLB Limited (SLB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 49 / 100
Financial Profile 49/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth
31

SLB Limited's revenue declined 1.6% year-over-year, from $36.3B to $35.7B. This contraction results in a growth score of 31/100.

Leverage
94

SLB Limited carries a low D/E ratio of 0.37, meaning only $0.37 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 94/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
22

SLB Limited's current ratio of 1.33 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow
59

SLB Limited has a free cash flow margin of 13.4%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
40

SLB Limited's ROE of 12.9% shows moderate profitability relative to equity, earning a score of 40/100. This is down from 21.1% the prior year.

Piotroski F-Score Neutral
4/9

SLB Limited passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.92x

For every $1 of reported earnings, SLB Limited generates $1.92 in operating cash flow ($6.5B OCF vs $3.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$35.7B
YoY-1.6%
5Y CAGR+8.6%
10Y CAGR+0.1%

SLB Limited generated $35.7B in revenue in fiscal year 2025. This represents a decrease of 1.6% from the prior year.

EBITDA
N/A
Net Income
$3.4B
YoY-24.4%
10Y CAGR+5.0%

SLB Limited reported $3.4B in net income in fiscal year 2025. This represents a decrease of 24.4% from the prior year.

EPS (Diluted)
$2.35
YoY-24.4%
10Y CAGR+3.7%

SLB Limited earned $2.35 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 24.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$4.8B
YoY+2.7%
5Y CAGR+21.3%
10Y CAGR-2.8%

SLB Limited generated $4.8B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 2.7% from the prior year.

Cash & Debt
$3.0B
YoY-14.3%
5Y CAGR+29.2%
10Y CAGR+0.8%

SLB Limited held $3.0B in cash against $9.7B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
1.50B
YoY+6.7%
5Y CAGR+1.4%
10Y CAGR+1.8%

SLB Limited had 1.50B shares outstanding in fiscal year 2025. This represents an increase of 6.7% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
9.4%
YoY-2.8pp
5Y CAGR+54.0pp
10Y CAGR+3.6pp

SLB Limited's net profit margin was 9.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.8 percentage points from the prior year.

Return on Equity
12.9%
YoY-8.2pp
5Y CAGR+100.0pp
10Y CAGR+7.1pp

SLB Limited's ROE was 12.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.2 percentage points from the prior year.

Capital Allocation

R&D Spending
$709.0M
YoY-5.3%
5Y CAGR+4.1%
10Y CAGR-4.2%

SLB Limited invested $709.0M in research and development in fiscal year 2025. This represents a decrease of 5.3% from the prior year.

Share Buybacks
$2.4B
YoY+39.0%
5Y CAGR+147.5%
10Y CAGR+1.0%

SLB Limited spent $2.4B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 39.0% from the prior year.

Capital Expenditures
$1.7B
YoY-12.3%
5Y CAGR+8.7%
10Y CAGR-3.5%

SLB Limited invested $1.7B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 12.3% from the prior year.

SLB Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $9.7B+9.1% $8.9B+4.5% $8.5B+0.7% $8.5B-8.6% $9.3B+1.4% $9.2B+0.2% $9.1B+5.0% $8.7B
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $187.0M+10.0% $170.0M-5.6% $180.0M+4.7% $172.0M-10.4% $192.0M+2.7% $187.0M-0.5% $188.0M+3.3% $182.0M
SG&A Expenses $85.0M+18.1% $72.0M-17.2% $87.0M-9.4% $96.0M+20.0% $80.0M-11.1% $90.0M-4.3% $94.0M-22.3% $121.0M
Operating Income N/A N/A N/A N/A N/A N/A N/A $1.6B
Interest Expense $127.0M-10.6% $142.0M0.0% $142.0M-3.4% $147.0M+12.2% $131.0M-3.7% $136.0M+3.0% $132.0M+16.8% $113.0M
Income Tax $143.0M-36.7% $226.0M-4.6% $237.0M+1.3% $234.0M-13.0% $269.0M-6.9% $289.0M+4.7% $276.0M+6.6% $259.0M
Net Income $824.0M+11.5% $739.0M-27.1% $1.0B+27.2% $797.0M-27.2% $1.1B-7.7% $1.2B+6.7% $1.1B+4.1% $1.1B
EPS (Diluted) N/A $0.50-32.4% $0.74+27.6% $0.58 N/A $0.83+7.8% $0.77+4.1% $0.74

SLB Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $54.9B-0.4% $55.1B+13.0% $48.8B-0.5% $49.0B+0.1% $48.9B-1.7% $49.8B+0.8% $49.4B+3.2% $47.9B
Current Assets $19.5B+0.2% $19.5B+5.5% $18.5B-0.8% $18.6B+0.1% $18.6B-1.2% $18.8B+1.5% $18.5B+4.6% $17.7B
Cash & Equivalents $3.0B+0.7% $3.0B-6.9% $3.2B+10.2% $2.9B-17.2% $3.5B+14.8% $3.1B+4.5% $3.0B+5.9% $2.8B
Inventory $5.0B-5.4% $5.3B+12.3% $4.7B+1.9% $4.7B+6.3% $4.4B-4.3% $4.6B+1.5% $4.5B-1.0% $4.5B
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $16.8B-1.3% $17.0B+16.0% $14.7B+0.1% $14.6B+0.3% $14.6B+0.2% $14.6B+0.2% $14.5B+3.2% $14.1B
Total Liabilities $27.6B-2.1% $28.2B+3.5% $27.2B-3.7% $28.3B+6.3% $26.6B-1.7% $27.0B-0.2% $27.1B+4.5% $25.9B
Current Liabilities $14.7B+4.9% $14.0B0.0% $14.0B-6.7% $15.0B+17.4% $12.8B+0.9% $12.7B+2.3% $12.4B-3.6% $12.9B
Long-Term Debt $9.7B-10.2% $10.8B-0.4% $10.9B+3.5% $10.5B-4.5% $11.0B-7.1% $11.9B-2.4% $12.2B+13.2% $10.7B
Total Equity $26.1B+1.8% $25.6B+26.3% $20.3B+4.0% $19.5B-7.6% $21.1B-1.8% $21.5B+2.1% $21.1B+1.6% $20.7B
Retained Earnings $18.1B+1.8% $17.7B+1.8% $17.4B+3.7% $16.8B+2.5% $16.4B+4.5% $15.7B+5.4% $14.9B+5.1% $14.2B

SLB Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $3.0B+78.7% $1.7B+47.3% $1.1B+73.0% $660.0M-72.4% $2.4B-2.4% $2.4B+70.5% $1.4B+339.1% $327.0M
Capital Expenditures $516.0M+26.2% $409.0M+10.2% $371.0M-6.8% $398.0M-34.6% $609.0M+32.4% $460.0M-0.6% $463.0M+16.0% $399.0M
Free Cash Flow $2.5B+95.5% $1.3B+65.1% $771.0M+194.3% $262.0M-85.3% $1.8B-10.5% $2.0B+104.4% $973.0M+1451.4% -$72.0M
Investing Cash Flow -$1.3B-2986.4% $44.0M-82.1% $246.0M+156.9% -$432.0M+9.4% -$477.0M+53.4% -$1.0B+31.4% -$1.5B-888.7% -$151.0M
Financing Cash Flow -$1.7B+10.9% -$1.9B-73.9% -$1.1B-26.5% -$878.0M+38.6% -$1.4B-10.5% -$1.3B-686.0% $221.0M+182.8% -$267.0M
Dividends Paid $426.0M+5.7% $403.0M+4.1% $387.0M+0.3% $386.0M-0.8% $389.0M-1.0% $393.0M-0.3% $394.0M+10.4% $357.0M
Share Buybacks $0-100.0% $114.0M $0-100.0% $2.3B+359.1% $501.0M0.0% $501.0M+7.7% $465.0M+72.2% $270.0M

SLB Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A 18.9%
Net Margin 8.5%+0.2pp 8.3%-3.6pp 11.9%+2.5pp 9.4%-2.4pp 11.8%-1.2pp 13.0%+0.8pp 12.2%-0.1pp 12.3%
Return on Equity 3.2%+0.3pp 2.9%-2.1pp 5.0%+0.9pp 4.1%-1.1pp 5.2%-0.3pp 5.5%+0.2pp 5.3%+0.1pp 5.1%
Return on Assets 1.5%+0.2pp 1.3%-0.7pp 2.1%+0.5pp 1.6%-0.6pp 2.2%-0.1pp 2.4%+0.1pp 2.3%+0.0pp 2.2%
Current Ratio 1.33-0.1 1.39+0.1 1.31+0.1 1.24-0.2 1.45-0.0 1.48-0.0 1.49+0.1 1.37
Debt-to-Equity 0.37-0.0 0.42-0.1 0.540.0 0.54+0.0 0.52-0.0 0.55-0.0 0.58+0.1 0.52
FCF Margin 25.5%+11.3pp 14.3%+5.2pp 9.0%+5.9pp 3.1%-16.1pp 19.2%-2.5pp 21.7%+11.1pp 10.7%+11.5pp -0.8%

Similar Companies

Frequently Asked Questions

SLB Limited (SLB) reported $35.7B in total revenue for fiscal year 2025. This represents a -1.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

SLB Limited (SLB) revenue declined by 1.6% year-over-year, from $36.3B to $35.7B in fiscal year 2025.

Yes, SLB Limited (SLB) reported a net income of $3.4B in fiscal year 2025, with a net profit margin of 9.4%.

SLB Limited (SLB) reported diluted earnings per share of $2.35 for fiscal year 2025. This represents a -24.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, SLB Limited (SLB) had $3.0B in cash and equivalents against $9.7B in long-term debt.

SLB Limited (SLB) had a net profit margin of 9.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

SLB Limited (SLB) has a return on equity of 12.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

SLB Limited (SLB) generated $4.8B in free cash flow during fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

SLB Limited (SLB) generated $6.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

SLB Limited (SLB) had $54.9B in total assets as of fiscal year 2025, including both current and long-term assets.

SLB Limited (SLB) invested $1.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

SLB Limited (SLB) invested $709.0M in research and development during fiscal year 2025.

Yes, SLB Limited (SLB) spent $2.4B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

SLB Limited (SLB) had 1.50B shares outstanding as of fiscal year 2025.

SLB Limited (SLB) had a current ratio of 1.33 as of fiscal year 2025, which is considered adequate.

SLB Limited (SLB) had a debt-to-equity ratio of 0.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

SLB Limited (SLB) had a return on assets of 6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

SLB Limited (SLB) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SLB Limited (SLB) has an earnings quality ratio of 1.92x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

SLB Limited (SLB) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top